-Naoya Kojima Researcher Activity Profile

Research Author Detailed Information 

Naoya Kojima Publication Rate By Year

Naoya Kojima has published 1 paper(s) in 2006, 9 paper(s) in 2007, 1 paper(s) in 2008, for a total of 11 research publications in total.

Naoya N Kojima Author Information

LAST NAME: kojima

FIRST NAME: naoya

INITIALS: N

AFFILIATION:

Papers

Naoya Kojima's Publication Record

1. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Year Published: 2006
Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.
2. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies. Year Published: 2007
Institute of Glycotechnology, Tokai University, Kanagawa 259-1292, Japan.
3. Structural alterations in outer arms of IgG oligosaccharides in patients with Werner syndrome. Year Published: 2007
Institute of Glycotechnology, Tokai University, Hiratsuka, Kanagawa, Japan.
4. A cholesterol-independent membrane microdomain serves as a functional counter-receptor for E-selectin at the Colo201 cell surface and initiates signalling on E-selectin binding. Year Published: 2007
The Institute of Glycotechnology, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.
5. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. Year Published: 2007
Department of Applied Biochemistry, School or Engineering, Tokai University, Kitakaname 1117, Hiratsuka-shi, Kanagawa 259-1292, Japan. asa@keyaki.cc.u-tokai.ac.jp
6. Structural alterations in outer arms of IgG oligosaccharides in patients with Werner syndrome. Year Published: 2007
Institute of Glycotechnology, Tokai University, Hiratsuka, Kanagawa, Japan.
7. A cholesterol-independent membrane microdomain serves as a functional counter-receptor for E-selectin at the Colo201 cell surface and initiates signalling on E-selectin binding. Year Published: 2007
The Institute of Glycotechnology, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.
8. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Year Published: 2007
Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.
9. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Year Published: 2007
Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.
10. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells. Year Published: 2008
Molecular Medicine Team of Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Centeral 2-12, Room 211, 1-1-1 Umezono, Tsukuba, Japan. yuzuru-ikehara@aist.go.jp
11. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Year Published: 2007
Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.